Measuring the health of nations: updating an earlier analysis

Health Affairs
Ellen Nolte, C Martin McKee

Abstract

We compared trends in deaths considered amenable to health care before age seventy-five between 1997-98 and 2002-03 in the United States and in eighteen other industrialized countries. Such deaths account, on average, for 23 percent of total mortality under age seventy-five among males and 32 percent among females. The decline in amenable mortality in all countries averaged 16 percent [corrected] over this period. The United States was an outlier, with a decline of only 4 percent. If the United States could reduce amenable mortality to the average rate achieved in the three top-performing countries, there would have been 101,000 fewer deaths per year by the end of the study period.

References

Mar 11, 1976·The New England Journal of Medicine·D D RutsteinE B Perrin
Nov 9, 2000·Leukemia·F LeviC La Vecchia
Apr 12, 2001·Australian and New Zealand Journal of Public Health·M Tobias, G Jackson
Oct 31, 2002·Social Science & Medicine·Ellen NolteMartin McKee
Oct 7, 2003·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·O A ArahT Custers
Nov 15, 2003·BMJ : British Medical Journal·Ellen Nolte, Martin McKee
Sep 22, 2006·Health Affairs·Cathy SchoenStephen C Schoenbaum
Feb 17, 2007·BMJ : British Medical Journal·Karen Davis

❮ Previous
Next ❯

Citations

Jun 9, 2012·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Richard HeijinkGert P Westert
Aug 11, 2010·Journal of General Internal Medicine·David W Bates
Aug 9, 2011·Health Economics, Policy, and Law·Laurent Degos, Victor G Rodwin
May 30, 2008·The New England Journal of Medicine·Irfan A Dhalla, Tara Kiran
Oct 24, 2008·The New England Journal of Medicine·Karen Davis
Aug 26, 2011·Journal of Public Health Policy·Stephen C SchoenbaumJoel C Cantor
May 18, 2010·European Journal of Public Health·Gretchen Stevens, Colin Mathers
Feb 14, 2013·European Journal of Public Health·Johan P Mackenbach, Martin McKee
Aug 28, 2010·Health Policy and Planning·Martin McKee
Jun 4, 2013·Social Work·Gary Miller
Mar 22, 2008·BMJ : British Medical Journal·Martin Roland
Jun 28, 2008·BMJ : British Medical Journal·Tony Delamothe
Feb 26, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·Stephan Moll, Nigel Mackman
Aug 5, 2010·BMC Health Services Research·Yue-Chune LeeEllen Nolte
Sep 12, 2012·BMC Health Services Research·Maria P FantiniGianfranco Damiani
May 1, 2010·Population Health Metrics·David FeenyBentson H McFarland
Oct 27, 2012·Israel Journal of Health Policy Research·Nehama Goldberger, Ziona Haklai
Mar 24, 2009·The Journal of Economic Perspectives : a Journal of the American Economic Association·Alan M Garber, Johathan Skinner
Aug 3, 2010·Healthcare Policy = Politiques De Santé·Robert G Evans
Jul 16, 2008·Annals of Family Medicine·Beat D SteinerL Allen Dobson
Oct 8, 2008·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Marcia Angell
Oct 20, 2010·Clinical Chemistry and Laboratory Medicine : CCLM·Phedias Diamandis
Feb 7, 2009·American Journal of Public Health·Thomas A Farley
Mar 20, 2010·American Journal of Public Health·Bobby MilsteinGary Hirsch
Feb 12, 2010·American Journal of Public Health·Irene Dankwa-MullanJohn Ruffin
Jul 23, 2011·American Journal of Public Health·Glorian SorensenUNKNOWN Workshop Working Group on Worksite Chronic Disease Prevention
Sep 21, 2010·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Roger Jones
Apr 29, 2011·The Libyan Journal of Medicine·Sliman Abdalah M Al-LagilliZoran Radojicic
Feb 21, 2014·Population Research and Policy Review·Irma T EloJames Macinko
Nov 25, 2014·Demographic Research·Christopher TenczaSamuel Preston
Apr 15, 2010·Social Indicators Research·Jeroen Klomp, Jakob de Haan
Jan 9, 2014·International Journal of Health Care Finance and Economics·Pablo Hernández de Cos, Enrique Moral-Benito
Jun 25, 2013·European Journal of Public Health·Alan WhiteGary Raine
Nov 2, 2014·Science·Sarah Harper
Jun 16, 2011·Population Health Metrics·Sandeep C KulkarniChristopher Jl Murray
Aug 3, 2010·Healthcare Policy = Politiques De Santé·Diane E Watson, Kimberlyn M McGrail
Oct 15, 2013·Seminars in Nephrology·Susanne B NicholasKeith C Norris
Sep 16, 2009·Journal of the American Pharmacists Association : JAPhA·David A Knapp
Dec 1, 2012·Health Policy·Stéphane Verguet, Dean T Jamison
Sep 19, 2012·Revista de calidad asistencial : organo de la Sociedad Española de Calidad Asistencial·J I Barrasa VillarF J Moliner Lahoz
Jun 1, 2012·Social Science & Medicine·Sonja LummeIlmo Keskimäki

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.